Both in Pharmaceuticals
Phio Pharmaceuticals vs Lisata Therapeutics
Over the past year PHIO returned −58.2% and LSTA returned −62.0%; their daily moves had a correlation of -0.01.
PHIO −58.2% LSTA −62.0%Growth of $1, one year, split-adjusted
| Metric | PHIO | LSTA |
|---|---|---|
| Price | $0.8626 | $1.01 |
| Market cap | $10.0M | $10.9M |
| Today | −5.91% | −4.72% |
| 1 month | −16.3% | −29.9% |
| 6 months | −29.3% | −67.6% |
| Year to date | −17.8% | −45.7% |
| 1 year | −60.1% | −63.7% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 109.1× |
| Net cash | $13.0M | $10.4M |
| Dividend yield | — | — |
| Volatility (60d) | 44.0% | 117.1% |
| Short % of float | 1.2% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).